Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 609

1.

Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.

Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS, You WC.

PLoS One. 2012;7(3):e33608. doi: 10.1371/journal.pone.0033608. Epub 2012 Mar 14.

2.

Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.

Cai H, Yuan Y, Hao YF, Guo TK, Wei X, Zhang YM.

Med Oncol. 2013 Mar;30(1):452. doi: 10.1007/s12032-012-0452-0. Epub 2013 Jan 10.

PMID:
23307259
3.

Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.

Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H.

Cancer Lett. 2012 Mar 28;316(2):196-203. doi: 10.1016/j.canlet.2011.10.034. Epub 2011 Nov 2.

PMID:
22169097
4.

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.

Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, Dai J, Ma H, Hu Z, Shen H, Xu Y, Jin G.

Br J Cancer. 2014 Apr 29;110(9):2291-9. doi: 10.1038/bjc.2014.119. Epub 2014 Mar 4.

5.

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O.

J Transl Med. 2012 Mar 22;10:55. doi: 10.1186/1479-5876-10-55.

6.

Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.

Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang Q, Chen L, Pang X, Leng W, Bi F.

Oncol Rep. 2014 Apr;31(4):1863-70. doi: 10.3892/or.2014.3004. Epub 2014 Jan 28.

PMID:
24481716
7.

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.

8.

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.

Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.

Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0. Epub 2015 Jun 15.

PMID:
26088272
9.

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.

Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.

Dis Markers. 2013;34(3):163-9. doi: 10.3233/DMA-120957.

10.

Analysis of serum genome-wide microRNAs for breast cancer detection.

Wu Q, Wang C, Lu Z, Guo L, Ge Q.

Clin Chim Acta. 2012 Jul 11;413(13-14):1058-65. doi: 10.1016/j.cca.2012.02.016. Epub 2012 Feb 23.

PMID:
22387599
11.

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.

Tang D, Shen Y, Wang M, Yang R, Wang Z, Sui A, Jiao W, Wang Y.

Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9.

PMID:
23462458
12.

Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis.

Zhu X, Lv M, Wang H, Guan W.

Dig Dis Sci. 2014 May;59(5):911-9. doi: 10.1007/s10620-013-2970-9. Epub 2013 Dec 12. Review.

PMID:
24337687
13.

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.

Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.

PLoS One. 2014 Mar 20;9(3):e92292. doi: 10.1371/journal.pone.0092292. eCollection 2014.

14.

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.

Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.

PLoS One. 2012;7(9):e44398. doi: 10.1371/journal.pone.0044398. Epub 2012 Sep 6.

15.

Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.

Wang H, Wang L, Wu Z, Sun R, Jin H, Ma J, Liu L, Ling R, Yi J, Wang L, Bian J, Chen J, Li N, Yuan S, Yun J.

Med Oncol. 2014 Dec;31(12):298. doi: 10.1007/s12032-014-0298-8. Epub 2014 Nov 4.

PMID:
25367852
16.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
17.

Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.

Kim SY, Jeon TY, Choi CI, Kim DH, Kim DH, Kim GH, Ryu DY, Lee BE, Kim HH.

J Mol Diagn. 2013 Sep;15(5):661-9. doi: 10.1016/j.jmoldx.2013.04.004. Epub 2013 Jun 25.

PMID:
23806809
18.

Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.

Fang C, Zhu DX, Dong HJ, Zhou ZJ, Wang YH, Liu L, Fan L, Miao KR, Liu P, Xu W, Li JY.

Ann Hematol. 2012 Apr;91(4):553-9. doi: 10.1007/s00277-011-1350-9. Epub 2011 Oct 11.

PMID:
21987025
19.

Circulating microRNAs in plasma of patients with gastric cancers.

Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2010 Mar 30;102(7):1174-9. doi: 10.1038/sj.bjc.6605608. Epub 2010 Mar 16.

20.

Identification of hsa-miR-335 as a prognostic signature in gastric cancer.

Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z, Chen F, Zheng G.

PLoS One. 2012;7(7):e40037. doi: 10.1371/journal.pone.0040037. Epub 2012 Jul 3.

Supplemental Content

Support Center